Direxion Daily Pharmaceutical & Medical Bull 2X Shares
PILL
PILL was delisted on the 31st of March, 2017.
1 hedge funds and large institutions have $2K invested in Direxion Daily Pharmaceutical & Medical Bull 2X Shares in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.37K |
Top Sellers
PILL Hedge Fund Activity: Q1 2017 in Review
1 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 2X Shares (PILL) for Q1 2017, worth a combined $2K.
Buyers outnumbered sellers: 1 fund opened new PILL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $2.37K.
- 1 institutional investor held Direxion Daily Pharmaceutical & Medical Bull 2X Shares (PILL) as of Q1 2017, up from 0 in Q4 2016.
- Funds reported $2K of Direxion Daily Pharmaceutical & Medical Bull 2X Shares stock for Q1 2017.
- 1 fund opened new Direxion Daily Pharmaceutical & Medical Bull 2X Shares positions in Q1 2017 and 0 closed out, a net change of +1 holder.
- The largest Direxion Daily Pharmaceutical & Medical Bull 2X Shares buyer in Q1 2017 was Tower Research Capital (TRC), an estimated $2.37K added.
Based on aggregated 13F filings for Q1 2017.